Andreas Hüser

749 total citations
11 papers, 563 citations indexed

About

Andreas Hüser is a scholar working on Molecular Biology, Biotechnology and Infectious Diseases. According to data from OpenAlex, Andreas Hüser has authored 11 papers receiving a total of 563 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Biotechnology and 2 papers in Infectious Diseases. Recurrent topics in Andreas Hüser's work include Viral Infectious Diseases and Gene Expression in Insects (5 papers), Transgenic Plants and Applications (4 papers) and Salivary Gland Disorders and Functions (2 papers). Andreas Hüser is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (5 papers), Transgenic Plants and Applications (4 papers) and Salivary Gland Disorders and Functions (2 papers). Andreas Hüser collaborates with scholars based in Germany, United States and Switzerland. Andreas Hüser's co-authors include Christian Hofmann, Michael Rudolph, Robert Strauss, André Lieber, Sebastian Tuve, Nancy B. Kiviat, Papa Salif Sow, Shaoheng Ni, Frank Wagner and Maximilian Posch and has published in prestigious journals such as Nature Biotechnology, Clinical Infectious Diseases and Annals of the Rheumatic Diseases.

In The Last Decade

Andreas Hüser

10 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Hüser Germany 9 323 197 103 91 90 11 563
Yanal Murad Canada 14 226 0.7× 108 0.5× 66 0.6× 209 2.3× 41 0.5× 26 583
Viraj Mane United States 12 362 1.1× 361 1.8× 120 1.2× 156 1.7× 17 0.2× 15 672
Anagha P. Phadke United States 10 223 0.7× 207 1.1× 81 0.8× 124 1.4× 95 1.1× 14 527
Saw-See Hong France 11 249 0.8× 104 0.5× 56 0.5× 44 0.5× 11 0.1× 17 480
Jewell Walters United States 12 385 1.2× 44 0.2× 95 0.9× 233 2.6× 38 0.4× 17 753
Mirko Arcuri Italy 7 93 0.3× 67 0.3× 39 0.4× 66 0.7× 44 0.5× 7 432
B. Sölder Austria 12 302 0.9× 52 0.3× 142 1.4× 146 1.6× 10 0.1× 21 603
Carole Kurahara United States 10 180 0.6× 129 0.7× 55 0.5× 390 4.3× 15 0.2× 12 682
Pamela A. Welch United States 10 94 0.3× 88 0.4× 50 0.5× 297 3.3× 12 0.1× 15 657
Vera A. Tang Canada 13 252 0.8× 70 0.4× 75 0.7× 186 2.0× 6 0.1× 25 575

Countries citing papers authored by Andreas Hüser

Since Specialization
Citations

This map shows the geographic impact of Andreas Hüser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Hüser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Hüser more than expected).

Fields of papers citing papers by Andreas Hüser

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Hüser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Hüser. The network helps show where Andreas Hüser may publish in the future.

Co-authorship network of co-authors of Andreas Hüser

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Hüser. A scholar is included among the top collaborators of Andreas Hüser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Hüser. Andreas Hüser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
2.
Dörner, Thomas, Maximilian Posch, Yue Li, et al.. (2019). Treatment of primary Sjögren's syndrome with ianalumab (VAY736) targeting B cells by BAFF receptor blockade coupled with enhanced, antibody-dependent cellular cytotoxicity. Annals of the Rheumatic Diseases. 78(5). 641–647. 126 indexed citations
3.
Wagner, Frank, Andreas Hüser, David Joseph, et al.. (2017). Safety, pharmacokinetics and pharmacodynamics of single rising doses of BI 655064, an antagonistic anti-CD40 antibody in healthy subjects: a potential novel treatment for autoimmune diseases. European Journal of Clinical Pharmacology. 74(2). 161–169. 30 indexed citations
4.
Lepeleire, Inge De, Randolph P. Matthews, Dirk Schürmann, et al.. (2017). O6 Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least 7 days. Journal of Virus Eradication. 3. 2–2.
5.
6.
Dörner, Thomas, Maximilian Posch, Florian Wagner, et al.. (2016). THU0313 Double-Blind, Randomized Study of VAY736 Single Dose Treatment in Patients with Primary Sjögren's Syndrome (PSS). Annals of the Rheumatic Diseases. 75. 300–301. 8 indexed citations
7.
Strauss, Robert, Andreas Hüser, Shaoheng Ni, et al.. (2006). Baculovirus-based Vaccination Vectors Allow for Efficient Induction of Immune Responses Against Plasmodium falciparum Circumsporozoite Protein. Molecular Therapy. 15(1). 193–202. 104 indexed citations
8.
Hüser, Andreas & Christian Hofmann. (2003). Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.. PubMed. 3(1). 53–63. 54 indexed citations
9.
Löser, Peter, et al.. (2002). Advances in the Development of Non-Human Viral DNA-Vectors for Gene Delivery. Current Gene Therapy. 2(2). 161–171. 34 indexed citations
10.
Hüser, Andreas, Michael Rudolph, & Christian Hofmann. (2001). Incorporation of decay-accelerating factor into the baculovirus envelope generates complement-resistant gene transfer vectors. Nature Biotechnology. 19(5). 451–455. 97 indexed citations
11.
Hofmann, Christian, et al.. (1999). Protection of Baculovirus-Vectors against Complement-Mediated Inactivation by Recombinant Soluble Complement Receptor Type 1. Biological Chemistry. 380(3). 393–5. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yanal Murad Breakdown of academic impact, for papers by Viraj Mane Breakdown of academic impact, for papers by Anagha P. Phadke Breakdown of academic impact, for papers by Saw-See Hong Breakdown of academic impact, for papers by Jewell Walters Breakdown of academic impact, for papers by Mirko Arcuri Breakdown of academic impact, for papers by B. Sölder Breakdown of academic impact, for papers by Carole Kurahara Breakdown of academic impact, for papers by Pamela A. Welch Breakdown of academic impact, for papers by Vera A. Tang
Rankless by CCL
2026